AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Venlaf ER 37.5 Tablet

Prescription Icon
Prescription Required

Marketer

Boston Pharma

Salt Composition

Venlafaxine (37.5mg)

Overview Venlaf ER 37.5 Tablet

Extended-release venlafaxine 37.5mg tablets treat depressive and anxiety disorders. This medication modifies brain chemistry, alleviating anxiety symptoms like agitation, hyperactivity, poor concentration, tiredness, perspiration, tachycardia, and racing thoughts. Take this tablet with food, consistently at the same time daily for steady blood levels. If a dose is missed, take it immediately upon recall; avoid skipping doses and complete the prescribed course, even with symptom improvement. Abrupt cessation may exacerbate symptoms, so gradual discontinuation is crucial. Common side effects—nausea, vomiting, sleep disturbances, reduced appetite, anxiety, constipation, increased sweating, and sexual difficulties—are often transient and self-limiting. Drowsiness and dizziness are possible; avoid driving or mentally demanding tasks until effects are known. Persistent or bothersome side effects require medical attention. Prior to use, disclose any kidney, heart, or liver conditions, or seizure history, to your physician. Report any unusual mood shifts, worsening depression, or suicidal ideation immediately.

Uses of Venlaf ER 37.5 Tablet

Mood disorders encompassing depressive and anxiety symptoms

Major Benefits of Venlaf ER 37.5 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Venlaf ER 37.5 mg tablets should be administered with a meal.

Common Side effects of Venlaf ER 37.5 Tablet:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Venlaf ER 37.5 Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Venlaf ER 37.5 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Venlaf ER 37.5 Tablet works:

Venlaf ER 37.5mg tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol and Venlaf ER 37.5 Tablets should not be taken together due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Venlaf ER 37.5 mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release venlafaxine 37.5 mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant. Close observation of newborns for appropriate weight gain and drowsiness is recommended.

DrivingDrivingUNSAFE

Driving ability may be impaired by Venlaf ER 37.5 mg tablets, due to potential side effects including dizziness, confusion, and visual disturbances like blurred vision.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Venlaf ER 37.5 mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Venlaf ER 37.5 mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Venlaf ER 37.5 Tablet :

Should you forget a Venlaf ER 37.5 Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Venlaf ER 37.5 Tablet

LabelValue
Chemical Classification Anisole-based compound
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Action Category SNRIs (serotonin-norepinephrine reuptake inhibitors)

FAQs on Venlaf ER 37.5 Tablet

Sedation is a possible side effect of Venlaf ER 37.5 mg tablets. Disclose all sleep aids you're using to your doctor before starting this medication.
Yes. Venlafaxine ER 37.5 mg tablets are psychotropic medications; these affect the mind, emotions, and behavior.
Venlafaxine ER 37.5 mg tablets are not narcotics. Narcotics are opioid-derived drugs, such as heroin and morphine, known for their sedative effects.
Venlafaxine ER 37.5 mg tablets (both ER and XR formulations) are identical extended-release medications. This extended-release design provides a slow, steady medication release, maintaining consistent therapeutic levels. The benefit is reduced dosing frequency.
Mirtazapine and Venlafaxine ER 37.5mg tablets together pose a serious risk of serotonin syndrome. This potentially life-threatening condition may manifest as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma.
Combining citalopram and venlafaxine ER 37.5 mg tablets raises serotonin levels dangerously, risking serotonin syndrome. This potentially fatal condition can manifest as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, fever, and coma. An alternative medication is necessary.
Venlafaxine ER 37.5 mg tablets are removed from the brain by P-glycoprotein, yet studies indicate that both this medication and its metabolite can inhibit P-glycoprotein activity.
Venlafaxine ER 37.5 mg tablets are absorbed in the intestine following hepatic metabolism.
Venlafaxine ER 37.5 mg tablets treat generalized anxiety disorder and depression. Always consult your physician before use.
Treatment with Venlaf ER 37.5 mg tablets may cause sustained high blood pressure in some individuals. Regular blood pressure monitoring is recommended for patients taking this medication; dose reduction or discontinuation may be necessary.
Constipation is a known side effect of Venlafaxine ER 37.5 mg tablets. Increase your fiber intake and water consumption. Laxatives may also help. Your doctor can advise on prevention and management. Contact your doctor if constipation persists or worsens.
Yes, Venlafaxine ER 37.5 mg tablets can cause weight loss in some individuals. Studies show this weight loss increases with higher doses and longer treatment periods. Talk to your doctor if this is a concern.
Venlafaxine ER 37.5 mg tablets are not considered habit-forming.
Consult your doctor before substituting a tablet for a capsule; the differing formulations may affect drug release and treatment efficacy, potentially causing side effects or treatment failure. Self-substitution is not recommended.
Yes, gabapentin and Venlaf ER 37.5 mg tablets can be used together, but only under a doctor's supervision. Concurrent use may increase drowsiness, sleepiness, and impair concentration. Exercise caution.
Desvenlafaxine is Venlaf ER 37.5 Tablet's active ingredient, essentially the same medication in its active state.
While Venlafaxine ER 37.5mg tablets haven't received approval for fibromyalgia treatment, some studies suggest potential benefits. Always consult your physician before using this medication for fibromyalgia.
While not FDA-approved for nerve pain, Venlafaxine ER 37.5 mg tablets show efficacy in some research and are therefore sometimes used off-label for this purpose.
Venlafaxine ER 37.5 mg tablets can alter brain neurotransmitter levels, resulting in reduced appetite. This appetite suppression is dose-related.
Experience decreased sex drive or impotence? Consult your doctor; alternative medications may be available. Never discontinue Venlaf ER 37.5 Tablet without medical supervision; doing so may worsen side effects.
Venlaf ER 37.5 Tablet
60
MRP 70
14% off